GALERX PHARAMACEUTICALS Trademark

Trademark Overview

On Monday, May 10, 2021, a trademark application was filed for GALERX PHARAMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the GALERX PHARAMACEUTICALS trademark a serial number of 90700551. The federal status of this trademark filing is REQUEST FOR FOURTH EXTENSION - FILED as of Friday, April 19, 2024. This trademark is owned by GaleRX Pharmaceuticals. The GALERX PHARAMACEUTICALS trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacture of human and veterinary medications by pharmaceutical compounders
galerx pharamaceuticals

General Information

Serial Number90700551
Word MarkGALERX PHARAMACEUTICALS
Filing DateMonday, May 10, 2021
Status721 - REQUEST FOR FOURTH EXTENSION - FILED
Status DateFriday, April 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 22, 2022

Trademark Statements

Goods and ServicesCustom manufacture of human and veterinary medications by pharmaceutical compounders
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, August 10, 2021
Primary Code040
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History

Party NameGaleRX Pharmaceuticals
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKennett Square, US 19348
Party NameGaleRX Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKennett Square, US 19348

Trademark Events

Event DateEvent Description
Thursday, May 13, 2021NEW APPLICATION ENTERED
Tuesday, August 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 13, 2022ASSIGNED TO EXAMINER
Tuesday, January 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 19, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 19, 2022SOU EXTENSION 1 FILED
Wednesday, October 19, 2022SOU EXTENSION 1 GRANTED
Friday, October 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 19, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 19, 2023SOU EXTENSION 2 FILED
Wednesday, April 19, 2023SOU EXTENSION 2 GRANTED
Friday, April 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 18, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 18, 2023SOU EXTENSION 3 FILED
Wednesday, October 18, 2023SOU EXTENSION 3 GRANTED
Friday, October 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 19, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 19, 2024SOU EXTENSION 4 FILED
Friday, April 19, 2024SOU EXTENSION 4 GRANTED
Saturday, April 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

pharamaceuticals galerx pharmaceutical compounders medications veterinary manufacture human custom